Federico Piacentini

PROF. ASSOCIATO

University of Modena and Reggio Emilia

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Federico Piacentini is an Associate Professor at the University of Modena and Reggio Emilia, Italy. His research focuses on breast cancer, specifically the biological characteristics of metastatic breast cancer, the role of imaging in evaluating body composition during treatment, and the application of next-generation sequencing in oncology. Additionally, he explores targeted therapies within hereditary cancer syndromes and the challenges of the PI3K/AKT/mTOR pathway in clinical settings.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Luciana Mastrodomenico

University of Modena and Reggio Emilia

ITALY

View details

Fabio Gelsomino

ITALY

View details

Massimo Dominici

University of Modena and Reggio Emilia

ITALY

View details

PIERFRANCO CONTE

Professore di 1^ fascia

University of Padova

ITALY

View details

Angela Toss

University of Modena and Reggio Emilia

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Federico Piacentini

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Role of Pectoralis Muscle Analysis in Breast Magnetic Resonance Imaging for Body Composition Evaluation Before and After Neoadjuvant Chemotherapy for Breast Cancer

Everolimus in the Treatment of Neuroendocrine Tumors: Lights and Shadows

Prognosis and biological characteristics of ER-low metastatic breast cancer: results from a multicenter cohort and the TONIC trial.

Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer

Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients

Personalized Systemic Therapies in Hereditary Cancer Syndromes

Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges

Carcinoid Crisis: A Misunderstood and Unrecognized Oncological Emergency

Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review

Ocular Toxicity in Breast Cancer Management: Manual for The Oncologist

Collaborators (5)

Luciana Mastrodomenico

Fabio Gelsomino

Massimo Dominici

PIERFRANCO CONTE

Angela Toss

Make your next move.